Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02453594
Brief Title: Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)

First Submitted : May 21, 2015
First Submitted that Met QC Criteria : May 21, 2015
First Posted : May 25, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 16, 2021
Last Update Posted : April 19, 2021